Organization Announcements

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.


Paul G. Allen Frontiers Group [to 27 Mar 2021] ess/
How old is this bat? A new DNA-based test can tell.
March 23, 2021
Molecular clock links immunity, cancer suppression to bats’ extraordinarily long lives; new method could also help conservation efforts…


BARDA – U.S. Department of HHS [to 27 Mar 2021]
No new digest content identified.


BMGF – Gates Foundation [to 27 Mar 2021]
Press Releases and Statements
No new digest content identified.


Bill & Melinda Gates Medical Research Institute [to 27 Mar 2021]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.


CARB-X [to 27 Mar 2021]
World’s leading funders of antibacterial research provide guidance on Stewardship and Access in the fight against antibiotic-resistant bacteria
Leading funders of research and development of new antibiotics and other products targeting antibiotic-resistant bacteria have just released a document providing comprehensive guidance on strategies and activities to support Stewardship and Access for companies bringing new antibacterial products to market. The Stewardship and Access Plan Development Guide provides companies with a framework to develop plans so that their product will be used responsibly, minimizing the spread of antibiotic-resistant bacteria while helping patients get access to life-saving products.


Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 27 Mar 2021]
:: Past weekly editions of Vaccines and Global Health: The Week in Review are available here.


CEPI – Coalition for Epidemic Preparedness Innovations [to 27 Mar 2021]
Latest News
No new digest content identified.


DARPA – Defense Advanced Research Projects Agency [to 27 Mar 2021
No new digest content identified.


Duke Global Health Innovation Center [to 27 Mar 2021]
No new digest content identified.


EDCTP [to 27 Mar 2021]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
24 March 2021
World TB Day: the promise of ending the TB epidemic


Emory Vaccine Center [to 27 Mar 2021]
Vaccine Center News
No new digest content identified.


European Commission [to 27 Mar 2021]
Statement 25 March 2021
Statement by President von der Leyen at the joint press conference with President Michel, following the videoconference of the members of the European Council
[See COVID above for detail]

Statement 24 March 2021
Joint statement by the European Commission and Her Majesty’s Government on cooperation in fighting the COVID-19 pandemic

Speech 24 March 2021
Remarks by Executive Vice-President Dombrovskis at the press conference on the export transparency and authorisation mechanism and an accelerated approval of adapted vaccines against COVID-19 variants
[See COVID above for detail]

Press release 24 March 2021
Coronavirus: new procedure to facilitate and speed up approval of adapted vaccines against COVID-19 variants
Today, as an immediate action under the HERA Incubator, the new European bio-defence preparedness plan against COVID-19 variants, the Commission is introducing a measure to speed up the authorisation of adapted COVID-19 vaccines. It will make provisions in the relevant EU legislation to allow companies to focus on gathering the necessary evidence in time and enable the authorisation of adapted vaccines with a smaller set of additional data submitted to the European Medicines Agency…


European Medicines Agency [to 27 Mar 2021]
News & Press Releases
News: Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna (new)
CHMP, Last updated: 26/03/2021
[See COVID above for detail]



News: EMA issues advice on use of regdanvimab for treating COVID-19 (new)
CHMP, Last updated: 26/03/2021



News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 March 2021 (new)
CHMP, Last updated: 26/03/2021



News: COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases (new)
PRAC, Last updated: 25/03/2021



News: EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials (new)
Last updated: 22/03/2021


European Vaccine Initiative [to 27 Mar 2021]
Latest News
March 23, 2021
World Tuberculosis Day 2021 – “The clock is ticking”…


FDA [to 27 Mar 2021]
Press Announcements /Selected Details
March 26, 2021 – Coronavirus (COVID-19) Update: March 26, 2021

March 23, 2021 – Coronavirus (COVID-19) Update: March 23, 2021


FDA – COVID-19 Vaccines [to 27 Mar 2021]
News and Updates; Upcoming Events
Coronavirus (COVID-19) Update
The FDA issues an emergency use authorization (EUA) to a company for the SARS-CoV-2 NGS Assay and provides a consumer update on common questions about COVID-19 vaccines.


Fondation Merieux [to 27 Mar 2021]
News, Events
Mérieux Foundation event
Vaccine Acceptance webinars: COVAX introduction & acceptance
March 29, 2021 – Virtual Event
These webinars will bring together international experts to showcase examples of challenges and success stories reported in specific countries during the COVID-19 vaccine introduction, adoption and implementation and the related crisis management aspects.
Session 1: March 29, 2021, 8:00 am – 10:30 am (CEST – Paris time)
Session 2: March 29, 2021, 4:00 pm – 6:30 pm (CEST – Paris time)
(Two separate sessions have been set up to facilitate worldwide connection).
To register for the virtual event please contact Marianne Gojon-Gerbelot.


Gavi [to 27 Mar 2021]
News Releases
25 March 2021
COVAX updates participants on delivery delays for vaccines from Serum Institute of India (SII) and AstraZeneca
[See COVID above for detail]

24 March 2021
Gavi Board approves COVAX Buffer for high-risk groups in humanitarian settings
[See COVID above for detail]


GHIT Fund [to 27 Mar 2021]
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
Press Releases
No new digest content identified.


Global Fund [to 27 Mar 2021]
News & Stories
TB testing in 2020 dropped drastically due to COVID-19
24 March 2021
On World Tuberculosis Day, new data shows the COVID-19 pandemic has had a devastating impact on the fight against another deadly airborne disease: tuberculosis. Global Fund surveys in 13 countries with the highest TB burden in the world reveal that 29% fewer people were tested for TB compared to 2019

Uganda’s Remarkable Response to COVID-19
23 March 2021


Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 27 Mar 2021]
Publication in The Lancet: A call to action for global R&D funders during epidemics
Funding organizations must address important gaps to establish a truly efficient and effective end-to-end R&D preparedness and response ecosystem.

COVID-19 research in low and middle income countries
March 29 & 30, 2021 – 12 pm – 4 pm (BST) – Online event The outline agenda for this…


Hilleman Laboratories [to 27 Mar 2021]
No new digest content identified.


Human Vaccines Project [to 27 Mar 2021]
No new digest content identified.


IAVI [to 27 Mar 2021]
March 24, 2021
Uhambo: Twists and turns on the journey to an efficacious HIV-1 vaccine
In a new commentary the New England Journal of Medicine (NEJM), Mark Feinberg, M.D., Ph.D., IAVI President and CEO underscores the importance of innovation in HIV vaccine development following the disappointing outcome of the HIV Vaccine Trials Network (HVTN) 702 study (termed Uhambo, Zulu for “journey”). Feinberg’s commentary follows the recent publication of findings from Uhambo today in NEJM.
Says Feinberg: “Even though the HVTN 702 results were disappointing, important recent data have indicated that a sufficient level of a broadly neutralizing antibody against HIV-1 (HIV bnAb) can protect at-risk persons from infection with bnAb-susceptible HIV-1 variants. These findings have established the breadth, potency, and concentration of HIV bnAb as a mechanistic correlate of protection. Although inducing protective bnAb responses by vaccination will be challenging, studies that combine high-resolution structural methods (including crystallography and cryogenic electron microscopy) to reveal important details regarding HIV-1 Env antigenic determinants and insights into how bnAb-producing B cells develop in a subgroup of patients with HIV infection have provided a promising direction for vaccine development. The ability of a defined vaccine immunogen to initiate the process of bnAb evolution in persons without HIV infection was recently shown.”…



International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.



International Generic and Biosimilar Medicines Association [IGBA]
Press Releases/Announcements
No new digest content identified.



Press Releases/Announcements
No new digest content identified.


IFRC [to 27 Mar 2021]
Selected Press Releases, Announcements
New Red Cross and Red Crescent plan to counter “deep and pervasive” inequities in pandemic response
Geneva, 24 March 2021 (ICRC/IFRC) – The International Red Cross and Red Crescent Movement has today launched a new plan that aims to tackle “deep and pervasive” inequities in the global response to the COVID-19 pandemic. While no one has been spared fr …
24 March 2021
[See COVID above for detail]

Europe, Kyrgyzstan, Russia, Tajikistan, Ukraine
World Tuberculosis Day: IFRC calls for increased TB detection and treatment amid pandemic
IFRC is urging decision-makers to ensure tuberculosis patients receive life-saving treatment during the COVID-19 pandemic, after new research showing the pandemic has set back TB detection by 12 years.
23 March 2021


Institut Pasteur [to 27 Mar 2021]
No new digest content identified.


IRC International Rescue Committee [to 27 Mar 2021]
Media highlights [Selected]
Press Release
Over 100% price increase in staple food contributes to dire humanitarian need as Yemen enters 7th year of war, says IRC
March 25, 2021

Press Release
The IRC condemns the multiple attacks against civilians in Niger that have killed over 200 people in just ten days
March 25, 2021

Press Release
IRC assessment finds women and children at risk of violence, sleeping on the street in Cox’s Bazar as major fire leaves over 45,000 people without shelter
March 23, 2021

Press Release
Syria: IRC statement on hospital attack in western Aleppo
March 21, 2021


IVAC [to 27 Mar 2021]
Updates; Events
Webinar Recording: SARS-CoV-2 Variants and the Safety of COVID-19 Vaccines in the U.S.
March 2021
The International Vaccine Access Center (IVAC) hosted a webinar on March 23, 2021, “SARS-CoV-2 Variants and the Safety of COVID-19 Vaccines in the U.S.” Description: This webinar presented about COVID-19 vaccine safety in the U.S. and the potential impact new variants will have on vaccine effectiveness. The speed and coordination of the response against COVID-19 […]


IVI [to 27 Mar 2021]
Selected IVI News, Announcements, Events
No new digest content identified.


JEE Alliance [to 27 Mar 2021]
Selected News and Events
No new digest content identified.


Johns Hopkins Center for Health Security [to 27 Mar 2021]
Center News
New Report: National Priorities to Combat Misinformation and Disinformation for COVID-19 and Future Public Health Threats: A Call for a National Strategy
March 23, 2021


MSF/Médecins Sans Frontières [to 27 Mar 2021]
Latest [Selected Announcements
Coronavirus COVID-19 pandemic
COVID-19 support desperately needed as second wave overwhelms Yemen
Press Release 25 Mar 2021

Coronavirus COVID-19 pandemic
Three questions on worrying COVID-19 surge in Papua New Guinea
Interview 25 Mar 2021

Coronavirus COVID-19 pandemic
Vaccines urgently needed as Palestine struggles under surge of COVID-19
Press Release 24 Mar 2021


National Vaccine Program Office – U.S. HHS [to 27 Mar 2021]
Upcoming Meetings/Latest Updates
No new digest content identified.


NIH [to 27 Mar 2021]
News Releases
Scientists find evidence that novel coronavirus infects the mouth’s cells
March 25, 2021 — NIH-funded findings point to a role for saliva in SARS-CoV-2 transmission.

NIAID Statement on AstraZeneca Vaccine
March 23, 2021 — Late Monday, the Data and Safety Monitoring Board (DSMB) notified NIAID, BARDA, and AstraZeneca that it was concerned by information released by AstraZeneca on initial data
[See COVID above for detail]

Investigational AstraZeneca vaccine prevents COVID-19
March 22, 2021 — Results are from a large clinical trial in the United States and South America.


UN OCHA Office for the Coordination of Humanitarian Affairs [to 27 Mar 2021]
Press Releases
No new digest content identified.


PATH [to 27 Mar 2021]
Press Releases
PATH welcomes Dr. Fredrick Were to the board of directors
March 23, 2021 by PATH
PATH’s board of directors has voted to appoint Dr. Fredrick Namenya Were as its new member. Dr. Were brings extensive experience in maternal and newborn health, child nutrition, health services and immunization.


Sabin Vaccine Institute [to 27 Mar 2021]
Statements and Press Releases
No new digest content identified.


UNAIDS [to 27 Mar 2021]
Selected Press Releases/Reports/Statements
26 March 2021
UNAIDS works with partners to support the COVID-19 recovery for vulnerable people in Indonesia

26 March 2021
UNAIDS shows that with the right investment we can end AIDS by 2030
A new report published by UNAIDS today shows the value of investing fully in the HIV response.
UNAIDS modelling shows that investing US$ 29 billion a year in the HIV response in low- and middle-income countries by 2025 will put the world back on track to end AIDS by 2030. The investment, paid for by both donors and the wealthier countries most impacted by the HIV pandemic, would result in annual new HIV infections falling dramatically, from 1.7 million in 2019 to 370 000 in 2025, and annual AIDS-related deaths falling from 690 000 in 2019 to 250 000 in 2025. The number of new HIV infections among children will drop from 150 000 in 2019 to less than 22 000 in 2025…

24 March 2021
Tuberculosis deaths among people living with HIV are declining globally, but worrying gaps in TB care persist

24 March 2021
Huge gaps in TB care for people living with HIV in some countries

24 March 2021
Drop-in centre provides a lifeline for sex workers in Ethiopia

24 March 2021
Drop-in centre for sex workers opened in Togo

22 March 2021
Digital HIV education for Jamaican young people during COVID-19 and beyond


UNDP United Nations Development Programme [to 27 Mar 2021]
Latest from News Centre
Women’s absence from COVID-19 task forces will perpetuate gender divide, says UNDP, UN Women
Women, on average, still make up only 24 percent of members among 225 COVID-19 task forces examined across 137 countries, as shown by the COVID-19 Global Gender Response Tracker tool that analyzes…
Posted on March 22, 2021


UNESCO [to 27 Mar 2021]
Selected Latest News
Ethical framework for COVID-19 response in the Arab region: views and recommendations from the experts


UNHCR Office of the United Nations High Commissioner for Refugees [to 27 Mar 2021]
Selected Announcements
Bangladeshi authorities, aid agencies and refugee volunteers rush to respond as massive fire leaves some 45,000 Rohingya refugees without shelter
23 Mar 2021


UNICEF [to 27 Mar 2021]
Selected Press releases, Statements
COVAX updates participants on delivery delays for vaccines from Serum Institute of India (SII) and AstraZeneca
[See COVID above for detail]

Press release
South Sudan receives first batch of COVID-19 vaccines through the COVAX Facility
JUBA, 25 March 2021 – Today 132,000 doses of the Astra Zeneca COVID-19 vaccine arrived at the Juba International Airport. This is the first of several vaccine shipments scheduled to arrive over the coming months to South Sudan through the support of the COVAX Facility…

Press release
Arrival of first wave consignment of COVAX COVID-19 vaccine doses to the State of Palestine
RAMALLAH and GAZA CITY, 21 March 2021 – On 17 March, the State of Palestine received the first shipment of 37,440 doses of the Pfizer COVID-19 vaccine and 24,000 doses of the Astra Zeneca COVID-19 vaccine from COVAX facility as part of the first wave allocation. These vaccine doses were transferred to the Ministry of Health’s ultra-cold chain and vaccine storage facilities in the West Bank and the Gaza Strip.
Further consignments of COVAX vaccine doses are planned for the State of Palestine to cover 20 per cent of the population – approximately 1 million people. As with the current consignments, these doses are for both the West Bank and the Gaza Strip, according to the prioritization criteria of the National Deployment and Vaccination Plan…


Unitaid [to 27 Mar 2021]
Featured News
24 March 2021
Unitaid reaffirms its commitment to combat tuberculosis in times of COVID-19
Geneva – On World Tuberculosis Day 2021, Unitaid renews its strong commitment to fight one the world’s deadliest infectious killers.
Ensuring wider access to better, simpler and more affordable solutions to stop the spread of tuberculosis (TB) has always been at the core of Unitaid’s mission. While the world has come together to combat the COVID-19 pandemic, it is now more important than ever to redouble our efforts when it comes to TB.
Every year, about 1.4 million die from TB and 10 million people fall ill with the disease. The COVID-19 pandemic has intensified existing access challenges to efficient prevention, diagnosis and care, threatening to reverse the gains made over recent years.
Disruptions in TB services, diversion of resources and substantial reductions in TB detection have been observed. Between 2020 and 2025, an additional 1.4 million TB deaths could be registered as direct consequence of the pandemic.
Urgent action must be taken to provide wider access to life-saving preventive tools, tests and treatments if we want to reach our objective of ending TB by 2030.
“In these exceptional times, innovation has proven to be even more critical than ever to tackle tuberculosis. We need to redouble our efforts across prevention, diagnosis and treatment to ensure that affordable, simpler and adapted solutions are made available in low- and middle-income countries, particularly for the people who need them the most” said Dr Philippe Duneton, Unitaid Executive Director.

24 March 2021
Unitaid looks to invest in better tools to improve tuberculosis detection


Vaccination Acceptance Research Network (VARN) [to 27 Mar 2021]
No new digest content identified.


Vaccine Confidence Project [to 27 Mar 2021]
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).


Vaccine Education Center – Children’s Hospital of Philadelphia [to 27 Mar 2021]
No new digest content identified.


Wellcome Trust [to 27 Mar 2021]
Why we need to share vaccine doses now and why COVAX is the right way to do it
26 March 2021

Has Covid-19 changed researcher behaviour?
Georgina Humphreys
25 March 2021


The Wistar Institute [to 27 Mar 2021]
Press Releases
Mar. 23, 2021
Richard M. Horowitz Appointed Chair of The Wistar Institute’s Board of Trustees
Richard M. Horowitz is the new Chair of Wistar’s Board of Trustees. Looking forward to future growth under his guidance, the Institute is grateful to former Chair Helen P. Pudlin for her inspiring leadership… Sue Dillon, Ph.D., who is co-founder and CEO of Aro Biotherapeutics, has been elected to serve as the new vice-chair. Dillon was previously global therapeutic area head, Immunology, at Janssen Research & Development, a pharmaceutical company of Johnson & Johnson.


WFPHA: World Federation of Public Health Associations [to 27 Mar 2021]
Latest News
No new digest content identified.


World Bank [to 27 Mar 2021]
Selected News, Announcements
New Global Tracker to Measure Pandemic’s Impact on Education Worldwide
Tracker a collaborative effort of Johns Hopkins University, the World Bank, and UNICEF March 26, 2021—The COVID-19 pandemic has disrupted education for 1.6 billion children worldwide over the past…
Date: March 26, 2021 Type: Press Release

WBG Vaccine Announcement– Key Facts
COVID-19 vaccines, alongside widespread testing, improved treatment and strong health systems are critical to save lives and strengthen the global economic recovery. To provide relief for vulnerable populations…
Date: March 23, 2021 Type: Factsheet
[See COVID above for detail]

COVID-19 in Eastern and Southern Africa: Four Hurdles to Recovery in the Race to Protect the Region’s Poorest
One year into the COVID-19 crisis, African countries in Eastern and Southern Africa have been spared the brunt of the pandemic, having recorded 2.1 million cases compared to, for example, close to 20 million…
Date: March 23, 2021 Type: Opinion


World Customs Organization – WCO [to 27 Mar 2021]
Latest News – Selected Items
No new digest content identified.


World Organisation for Animal Health (OIE) [to 27 Mar 2021]
Press Releases
No new digest content identified.


WTO – World Trade Organisation [to 27 Mar 2021]
WTO News and Events
Post-COVID-19 recovery must not leave anyone behind — DG Okonjo-Iweala at Aid for Trade event
23 March 2021
WTO Director-General Ngozi Okonjo-Iweala, joined by five heads of international organizations, stressed the need to keep global trade flows open to ensure that developing and least-developed countries have access to essential medical goods to control the spread of COVID-19 and are able to use trade to drive sustainable economic recovery. The speakers were taking part in a high-level plenary session held on Day 1 of the online Aid for Trade Stocktaking Event on 23 March.





ARM [Alliance for Regenerative Medicine] [to 27 Mar 2021]
Press Releases – Alliance for Regenerative Medicine (
Press Releases
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments
BRUSSELS, BELGIUM – March 24, 2021
European Patients Stand To Benefit From Early Focus On Life-Changing ATMPs
The Alliance for Regenerative Medicine (ARM) – the global voice of the regenerative medicine and advanced therapies sector – welcomes the Council of the European Union’s support for EU-level joint clinical assessments. If adopted, joint clinical assessments can eliminate duplicative reviews of transformative Advanced Therapy Medicinal Products (ATMPs) across member states, reducing the time and cost required to bring durable, and potentially curative, cell, gene, and tissue-based therapies to patients anywhere in the EU…


BIO [to 27 Mar 2021]
Press Releases
No new digest content identified.


DCVMN – Developing Country Vaccine Manufacturers Network [to 27 Mar 2021]
News; Upcoming events
No new digest content identified.


ICBA – International Council of Biotechnology Associations [to 27 Mar 2021]
No new digest content identified.


IFPMA [to 27 Mar 2021]
Selected Press Releases, Statements, Publications
R&D-based pharmaceutical industry’s innovative partnerships to meet urgent global supply needs
23 March 2021


PhRMA [to 27 Mar 2021]
Selected Press Releases, Statements
New report demonstrates the growing importance of partnerships in advancing biomedical innovation
March 24, 2021
…The report Power and Promise of a Collaborative Biopharmaceutical Ecosystem provides a look at the various collaborative partnerships currently taking place across the research ecosystem and healthcare system, playing a crucial role in:
:: Catalyzing research and development (R&D) and innovation,
:: Supporting public health and improving patient outcomes,
:: Enabling manufacturing scalability and supporting distribution and
:: Improving access to cutting edge innovation and cures.